Location: Palo Alto, CA
CIK: 0001892134 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $3.887B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | 4,009,240 | $38.17M | 1.0% | $7.00 | 0.0% | COM | 09058V103 |
| ACRS | ACLARIS THERAPEUTICS INC | 4,925,374 | $18.47M | 0.5% | $3.33 | 0.0% | COM | 00461U105 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 1,000,000 | $16.45M | 0.4% | $20.66 | 0.0% | COM | 61225M102 |
| XLO | XILIO THERAPEUTICS INC | 422,505 | $3.553M | 0.1% | $8.41 | — | COM | 98422T209 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ERAS | ERASCA INC | 24,675,188 (+8.6%) | $399M (+372.2%) | 10.3% | $2.81 | +257.2% | COM | 29479A108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 7,679,684 (+13.0%) | $709M (+32.2%) | 18.3% | $32.60 | +196.2% | COM | 604749101 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 882,400 (+22.1%) | $110M (+45.5%) | 2.8% | $29.86 | +206.0% | COM | 697947109 |
| CYTK | CYTOKINETICS INC | 1,159,879 (+24.1%) | $76.45M (+28.7%) | 2.0% | $43.44 | +48.3% | COM NEW | 23282W605 |
| IRON | DISC MEDICINE INC | 1,354,852 (+7.5%) | $86.63M (-13.4%) | 2.2% | $38.49 | +92.4% | COM | 254604101 |
| MNKD | MANNKIND CORP | 5,900,000 (+39.6%) | $14.46M (-39.7%) | 0.4% | $5.52 | +0.8% | COM NEW | 56400P706 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,438,198 (+10.9%) | $32.01M (-7.6%) | 0.8% | $23.92 | +5.4% | COM | 004225108 |
| IMCR | IMMUNOCORE HLDGS PLC | 484,782 (+26.0%) | $14.62M (+9.4%) | 0.4% | $31.01 | — | ADS | 45258D105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RNAM | AVIDITY BIOSCIENCES INC | 983,125 | $70.91M | 1.8% | $43.19 | +68.2% | — | 05370A108 |
| ABVX | ABIVAX SA | 378,300 | $51.02M | 1.3% | $84.90 | — | — | 00370M103 |
| RAPT | RAPT THERAPEUTICS INC | 983,333 | $33.31M | 0.9% | $31.06 | +62.6% | — | 75382E208 |
| TVTX | TRAVERE THERAPEUTICS INC | 241,592 | $9.231M | 0.2% | $16.57 | +87.2% | — | 89422G107 |
| DSGN | DESIGN THERAPEUTICS INC | 521,000 | $4.887M | 0.1% | $4.24 | +135.3% | — | 25056L103 |
| XLO | XILIO THERAPEUTICS INC | 5,915,091 | $3.787M | 0.1% | $0.75 | -19.5% | — | 98422T100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| KALV | KALVISTA PHARMACEUTICALS INC | 4,961,108 (-1.6%) | $99.87M (+22.7%) | 2.6% | $10.00 | +54.9% | COM | 483497103 |
| BBIO | BRIDGEBIO PHARMA INC | 3,448,139 (-2.7%) | $256M (-5.6%) | 6.6% | $21.54 | +245.7% | COM | 10806X102 |
| TRVI | TREVI THERAPEUTICS INC | 9,939,547 (-3.1%) | $119M (-7.7%) | 3.1% | $2.91 | +275.8% | COM | 89532M101 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,256,080 (-1.8%) | $42.49M (+22.0%) | 1.1% | $31.94 | -12.2% | COM | 00847X104 |
| SVRA | SAVARA INC | 9,720,852 (-1.4%) | $53.08M (-10.8%) | 1.4% | $3.69 | +54.5% | COM | 805111101 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3,796,668 (-1.9%) | $9.264M (+74.8%) | 0.2% | $3.58 | -51.5% | COM | 019770106 |
| KRYS | KRYSTAL BIOTECH INC | 481,307 (-1.5%) | $124M (+3.2%) | 3.2% | $64.17 | +324.5% | COM | 501147102 |
| AUTL | AUTOLUS THERAPEUTICS LTD | 4,447,910 (-3.8%) | $6.138M (-33.3%) | 0.2% | $4.59 | — | SPON ADS | 05280R100 |
| RVMD | REVOLUTION MEDICINES INC | 675,686 (-15.3%) | $65.71M (+3.5%) | 1.7% | $25.35 | +306.4% | COM | 76155X100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PHAT | PHATHOM PHARMACEUTICALS INC | 12,466,489 | $139M | 3.6% | $12.14 | +12.8% | COM | 71722W107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 9,874,511 | $233M | 6.0% | $16.74 | +60.4% | COM | 03969K108 |
| MAZE | MAZE THERAPEUTICS INC | 4,567,274 | $136M | 3.5% | $11.88 | +270.6% | COM | 578784100 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 16,943,774 | $542M | 14.0% | $13.41 | +151.6% | ORDINARY SHARES | N62509109 |
| LXEO | LEXEO THERAPEUTICS INC | 4,424,725 | $25.4M | 0.7% | $5.15 | +46.2% | COM | 52886X107 |
| VOR | VOR BIOPHARMA INC | 2,543,939 | $45.38M | 1.2% | $18.62 | -24.9% | COM NEW | 929033207 |
| MBX | MBX BIOSCIENCES INC | 6,652,013 | $199M | 5.1% | $21.92 | +68.0% | COM | 55287L101 |
| TARS | TARSUS PHARMACEUTICALS INC | 728,644 | $51.11M | 1.3% | $17.82 | +291.1% | COM | 87650L103 |
| EOLS | EVOLUS INC | 2,630,665 | $10.81M | 0.3% | $10.05 | -51.3% | COM | 30052C107 |
| AURA | AURA BIOSCIENCES INC | 5,100,000 | $34.12M | 0.9% | $5.85 | -7.0% | COM | 05153U107 |
| VALN | VALNEVA SE | 2,291,666 | $14.32M | 0.4% | $8.03 | — | SPONSORED ADS | 92025Y103 |
| ALKS | ALKERMES PLC | 700,647 | $24.77M | 0.6% | $27.95 | +15.7% | SHS | G01767105 |
| DYN | DYNE THERAPEUTICS INC | 3,153,082 | $57.17M | 1.5% | $13.76 | +24.4% | COM | 26818M108 |
| ZLAB | ZAI LAB LTD | 1,902,320 | $35.78M | 0.9% | $32.50 | — | ADR | 98887Q104 |
| ASND | ASCENDIS PHARMA A/S | 133,333 | $30.5M | 0.8% | $149.31 | — | SPONSORED ADR | 04351P101 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 500,333 | $10.03M | 0.3% | $0.87 | — | *W EXP 99/99/999 | N62509117 |
| IBIO | IBIO INC | 1,953,467 | $3.712M | 0.1% | $1.36 | +69.5% | COM NEW | 451033708 |